Three medical groups have issued guidelines for the use of anticoagulants during cardiac surgery.
The DOAC edoxaban can replace dalteparin for treating cancer patients with venous thromboembolism.
The chain patented new tech to help better manage oncolytic usage.
Hurdles to adoption of biosimilars include regulatory issues and lack of interchangeability with the reference drugs.
Will healthcare manufacturing in Puerto Rico be back on its feet by next hurricane season?
Pharmacists need to stay informed about new technologies in order to help diabetic patients take advantage.
New study finds just how much people like and trust their pharmacists.
Research finds that pharmacists in ACOs improve medication use (and save money).
Easy-to-swallow bits of information from around the world of pharmacy.
New plans are designed around feedback and a desire to increase safety checks.